BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27347346)

  • 1. Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/β-catenin pathway.
    Li Z; Zhao L; Wang Q
    Am J Transl Res; 2016; 8(5):2385-93. PubMed ID: 27347346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA HOTTIP promotes endothelial cell proliferation and migration via activation of the Wnt/β-catenin pathway.
    Liao B; Chen R; Lin F; Mai A; Chen J; Li H; Xu Z; Dong S
    J Cell Biochem; 2018 Mar; 119(3):2797-2805. PubMed ID: 29058802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of the long noncoding RNA HOTTIP inhibits cell proliferation and enhances cell sensitivity to cisplatin by suppressing the Wnt/β-catenin pathway in prostate cancer.
    Jiang H; Xiong W; Chen L; Lv Z; Yang C; Li Y
    J Cell Biochem; 2019 Jun; 120(6):8965-8974. PubMed ID: 30809864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA HOTTIP enhances human osteogenic BMSCs differentiation via interaction with WDR5 and activation of Wnt/β-catenin signalling pathway.
    Liu R; Li Z; Song E; Hu P; Yang Q; Hu Y; Liu H; Jin A
    Biochem Biophys Res Commun; 2020 Apr; 524(4):1037-1043. PubMed ID: 32067741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long noncoding RNA HOTTIP promotes breast cancer cell migration, invasiveness, and epithelial-mesenchymal transition via the Wnt-β-catenin signaling pathway.
    Han S; Jin X; Liu Z; Xing F; Han Y; Yu X; He G; Qiu F
    Biochem Cell Biol; 2019 Oct; 97(5):655-664. PubMed ID: 30676763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer.
    Li J; Yang S; Su N; Wang Y; Yu J; Qiu H; He X
    Tumour Biol; 2016 Feb; 37(2):2057-65. PubMed ID: 26341496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
    Li F; Cao L; Hang D; Wang F; Wang Q
    Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z; Jiang C; Fang J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/β-catenin signaling pathway.
    Zhao H; Hou W; Tao J; Zhao Y; Wan G; Ma C; Xu H
    Am J Transl Res; 2016; 8(8):3503-12. PubMed ID: 27648140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
    Wu Z; Shi W; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
    Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma.
    He J; Ling L; Liu Z; Ren X; Wan L; Tu C; Li Z
    Cancer Cell Int; 2021 Jun; 21(1):313. PubMed ID: 34130697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G; Zhang C; Wang N; Chen J
    Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between long non-coding RNAs and Wnt/β-catenin signalling in cancer.
    Yang G; Shen T; Yi X; Zhang Z; Tang C; Wang L; Zhou Y; Zhou W
    J Cell Mol Med; 2018 Apr; 22(4):2062-2070. PubMed ID: 29392884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallic acid mediates tumor-suppressive effects on osteosarcoma through the H19-Wnt/β-catenin regulatory axis.
    Pang F; Ding S; Li N; Li Z; Tian N; Shi C; Zhang F; Mai Y; Zhang J; Wang J
    J Orthop Translat; 2023 Mar; 39():34-42. PubMed ID: 36636358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA HOTTIP is a significant indicator of ovarian cancer prognosis and enhances cell proliferation and invasion.
    Zou T; Wang PL; Gao Y; Liang WT
    Cancer Biomark; 2019; 25(2):133-139. PubMed ID: 30452402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of circ_001569 is upregulated in osteosarcoma and promotes cell proliferation and cisplatin resistance by activating the Wnt/β-catenin signaling pathway.
    Zhang H; Yan J; Lang X; Zhuang Y
    Oncol Lett; 2018 Nov; 16(5):5856-5862. PubMed ID: 30344736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
    Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
    Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.